Jamie P Dwyer

Summary

Affiliation: Vanderbilt University
Country: USA

Publications

  1. doi request reprint Nonproteinuric diabetic nephropathy: when diabetics don't read the textbook
    Jamie P Dwyer
    Division of Nephrology and Hypertension, and Nephrology Clinical Trials Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA
    Med Clin North Am 97:53-8. 2013
  2. ncbi request reprint Evaluation of renal artery stenosis in dialysis patients
    Jamie P Dwyer
    Division of Nephrology Hypertension, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA
    Semin Dial 22:519-23. 2009
  3. doi request reprint Dose-response and efficacy of ferric citrate to treat hyperphosphatemia in hemodialysis patients: a short-term randomized trial
    Jamie P Dwyer
    Division of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, TN 37232, USA
    Am J Kidney Dis 61:759-66. 2013
  4. doi request reprint In-center thrombolysis for clotted AV access: a cohort review
    Kausik Umanath
    Division of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA
    Semin Dial 26:124-9. 2013
  5. doi request reprint Optimizing blood pressure control in patients with nondiabetic glomerular disease
    Kausik Umanath
    Division of Nephrology and Hypertension, Henry Ford Hospital, Detroit, MI Division of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, TN and Division of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, TN
    Adv Chronic Kidney Dis 21:200-4. 2014
  6. doi request reprint Rationale and study design of a three-period, 58-week trial of ferric citrate as a phosphate binder in patients with ESRD on dialysis
    Kausik Umanath
    Division of Nephrology and Hypertension, Henry Ford Hospital, Detroit, MI, USA
    Hemodial Int 17:67-74. 2013

Collaborators

Detail Information

Publications6

  1. doi request reprint Nonproteinuric diabetic nephropathy: when diabetics don't read the textbook
    Jamie P Dwyer
    Division of Nephrology and Hypertension, and Nephrology Clinical Trials Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA
    Med Clin North Am 97:53-8. 2013
    ..A well-designed biopsy study and a series of intervention trials are needed to fully understand this entity...
  2. ncbi request reprint Evaluation of renal artery stenosis in dialysis patients
    Jamie P Dwyer
    Division of Nephrology Hypertension, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA
    Semin Dial 22:519-23. 2009
    ..The risks of intervention must be weighed against the potential for renal recovery, even when predictors of success are not known with certainty...
  3. doi request reprint Dose-response and efficacy of ferric citrate to treat hyperphosphatemia in hemodialysis patients: a short-term randomized trial
    Jamie P Dwyer
    Division of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, TN 37232, USA
    Am J Kidney Dis 61:759-66. 2013
    ..Most dialysis patients require phosphate binders to control hyperphosphatemia. Ferric citrate has been tested in phase 2 trials as a phosphate binder. This trial was designed as a dose-response and efficacy trial...
  4. doi request reprint In-center thrombolysis for clotted AV access: a cohort review
    Kausik Umanath
    Division of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA
    Semin Dial 26:124-9. 2013
    ..Thus, this modified lyse-and-wait protocol can be adopted with appropriate IR and surgical backup in place...
  5. doi request reprint Optimizing blood pressure control in patients with nondiabetic glomerular disease
    Kausik Umanath
    Division of Nephrology and Hypertension, Henry Ford Hospital, Detroit, MI Division of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, TN and Division of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, TN
    Adv Chronic Kidney Dis 21:200-4. 2014
    ..Renin-angiotensin system inhibitors should be used as the cornerstone of therapy for all patients with glomerular disease and CKD. ..
  6. doi request reprint Rationale and study design of a three-period, 58-week trial of ferric citrate as a phosphate binder in patients with ESRD on dialysis
    Kausik Umanath
    Division of Nephrology and Hypertension, Henry Ford Hospital, Detroit, MI, USA
    Hemodial Int 17:67-74. 2013
    ..If proven safe and efficacious, ferric citrate will likely provide an additional phosphate binder to treat chronic kidney disease associated mineral and bone disorders...